"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Alivus Life Sciences Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Hiren K. Patel
Home : Indian Private	Book Value: 271.4099527
BSE Code : 543322	Market Cap: 16493.73
NSE Code : ALIVUS	P / E : 26.53

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025
Type	1Qtr	4Qtr	3Qtr	2Qtr
Net Sales	640.41	689.12	672.89	587.98
Other Income	22.40	22.78	13.93	14.72
Total Income	662.82	711.90	686.82	602.70
Total Expenditure	428.70	474.59	467.27	408.81
Operating Profit	234.12	237.31	219.54	193.89
Interest	1.31	1.31	1.49	1.32
Gross Profit	232.81	236.00	218.05	192.57
Depreciation	20.59	20.20	19.66	18.44
Tax	50.27	51.09	53.92	39.95
Deferred Tax	1.87	2.05	-5.79	4.16
Reported Profit After Tax	160.08	162.66	150.26	130.03

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
Research Analyst SEBI Reg. No.INH000001527 | Research Analyst BSE Enlistment Number: 5104

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481